PR Newswire - Telix Exceeds FY24 Guidance with US$142M Q4 Revenu...
MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today provides an update on its commercial and ope...
Read More

ภาษาไทย
English